We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.65 | 4.36 | 4.99 | - | 128,564 | 08:00:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/7/2020 23:48 | Vikingwarrier25 Jul '20 - 12:18 - 11251 of 11729 0 3 0 I can realistically see £100 a share here Vikingwarrier25 Jul '20 - 12:18 - 11252 of 11729 0 0 0 That was pounds ——— Criminal p&dMerchaaants. & tht nobhead cnt doesntBan Him but bansMe wtf???? PumpersWilBe dumping Soon | andymunchkin | |
28/7/2020 23:39 | strongbuy25 Jul '20 - 09:03 - 11235 of 11728 0 2 0 Simon, I agree and would not be surprised if they simply launched a takeover once the FDA tip them off how much of a game changer the drug is !! ——— Ffs nesto’ rampers. Go& ask AZ why theyRefused 20 years ago | andymunchkin | |
28/7/2020 23:30 | This is from the LSE board just now... Anna Sharratt 2 hours ago Eleanor Fish (Professor of immunology at the University of Toronto) says a new clinical trial is set to start in weeks in the U.S. that will look at the effectiveness of IFN-B against the coronavirus. “If the results look very promising that certain individuals are doing very well, then they’ll do what’s called unblinding,” says Fish. Unblinding means that the people involved in the trial who have not received the drug will have access to it. Elanor says ewe should be stockpiling the drug asap. For reference Eleanor Fish is an advisor to Betterlife Pharma who are creating a similar inhaled treatment using Interferon-alpha. Note she says IFN-B and not IFN-A is due to trial in USA. The only company with the patent for inhaled IFN-B is Synairgen. I suspect we have been given the green light for phase 3 trial. | oranolio | |
28/7/2020 23:28 | simon_6425 Jul '20 - 08:39 - 11233 of 11728 0 6 0 Strong buy My mum said something similar last night, she said Trump would find some way to snap the company up and make sure America has ALL the supply. ——— Pmsl RampingCnt alert | andymunchkin | |
28/7/2020 23:21 | bag158s24 Jul '20 - 14:50 - 11170 of 11728 0 2 0 Yes. News could be on Monday or Tuesday re FDA approval. It should go a lot higher. ——— RampingCnts withCriminal Lies | andymunchkin | |
28/7/2020 23:14 | bowssbyjuhelm24 Jul '20 - 09:59 - 11117 of 11728 0 1 2 When ramping please refrain from giving specific times.. lol may end up looking like a bit of a mug :) ——— RampingMungs In ferAsurpriZe | andymunchkin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions